|
|
Article: Afid Therapeutics Inc Expands Diversification and Market Thrust: Lands Third Order from Major Aerospace Companies for Advanced Glyco-based Reactant.
- Article from:
- PR Newswire
- Article date:
- August 19, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LANSING, Mich., Aug. 19 /PRNewswire/ -- Afid Therapeutics Inc announced today that it had received the third of three anticipated orders from leading aerospace companies for a new high purity reactant that it prepares from plant materials using its large repertoire of carbohydrate-based chemistry. The company utilizes raw materials obtained from readily available high-volume processing residue from crops such as corn and sugar beet. It then carries out chemical transformations on these to make advanced intermediates used in a wide spectrum of applications. The first products were developed for the pharmaceutical and general drug discovery and development industries. The ...
Related newspaper, magazine, and journal articles:
|
|
Article: Michigan Pre-Seed Capital Fund Invests in 3 More ...
PR Newswire;
July 7, 2008 ;
700+ words
... ... to retain business here in Michigan as well as attract and retain ... received funding through the Michigan Pre-Seed Capital Fund ... BioMaterials, Ann Arbor -- Afid Therapeutics, Lansing -- Avidimer Therapeutics ... Sciences, Inc., Lansing The Michigan Pre-Seed Capital Fund is ...
|
|